| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 129.93B | 135.21B | 125.91B | 115.73B | 106.13B | 94.45B |
| Gross Profit | 28.90B | 29.27B | 27.94B | 24.42B | 20.65B | 19.07B |
| EBITDA | 16.46B | 17.69B | 15.62B | 13.60B | 12.44B | 11.80B |
| Net Income | 11.29B | 11.64B | 10.63B | 7.29B | 8.00B | 7.85B |
Balance Sheet | ||||||
| Total Assets | 74.77B | 85.25B | 81.35B | 85.77B | 81.11B | 79.43B |
| Cash, Cash Equivalents and Short-Term Investments | 26.89B | 30.57B | 30.52B | 39.40B | 44.33B | 47.32B |
| Total Debt | 504.00M | 0.00 | 199.00M | 600.00M | 197.00M | 233.36M |
| Total Liabilities | 17.77B | 20.56B | 22.00B | 22.36B | 18.73B | 17.29B |
| Stockholders Equity | 55.74B | 63.51B | 58.06B | 62.27B | 61.42B | 62.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.49B | 9.14B | 10.15B | 7.36B | 7.53B |
| Operating Cash Flow | 0.00 | 8.96B | 9.67B | 10.43B | 7.66B | 7.67B |
| Investing Cash Flow | 0.00 | 59.00M | -2.81B | -8.54B | -949.00M | -217.88M |
| Financing Cash Flow | 0.00 | -8.09B | -16.09B | -7.82B | -9.10B | -5.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥85.19B | 13.83 | ― | 2.32% | 8.80% | 16.40% | |
72 Outperform | ¥316.58B | 20.13 | ― | 0.22% | 23.27% | 67.12% | |
71 Outperform | ¥152.20B | 13.05 | ― | 2.30% | 12.89% | 36.13% | |
68 Neutral | ¥162.93B | 13.13 | 18.89% | 2.78% | 7.39% | 14.95% | |
68 Neutral | ¥142.58B | 13.67 | 11.52% | 2.76% | 4.79% | 15.28% | |
65 Neutral | ¥30.17B | 20.84 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |